Alpha 2.0
Login Register
» Authors » R J MacFadyen

R J MacFadyen

Explore the profile of R J MacFadyen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 453
Followers 0
Related Specialties
General Medicine
Cardiology & Vascular Diseases
Pharmacology
Top 10 Co-Authors
J L Reid
K R Lees
A D Struthers
T M MacDonald
G Y H Lip
M H Tayebjee
P A MEREDITH
J K Doig
P O Lim
N Prasad
Published In
Br J Clin Pharmacol
J Hum Hypertens
Heart
J Cardiovasc Pharmacol
J R Coll Physicians Edinb
Affiliations
Soon will be listed here.
Recent Articles
1.
Associations and clinical significance in meta-analysis: when are the deductions too presumptive?
MacFadyen R
J R Coll Physicians Edinb . 2014 Jul; 44(2):131-2. PMID: 24999775
No abstract available.
2.
Basic physical examination: a valid expectation, not an option
MacFadyen R
J R Coll Physicians Edinb . 2012 Dec; 42(4):292-3. PMID: 23240112
No abstract available.
3.
Referral for diagnosis: effectiveness not activity or expediency is a priority
MacFadyen R
J R Coll Physicians Edinb . 2012 Mar; 42(1):5-7. PMID: 22441055
No abstract available.
4.
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus
Jaumdally R, Lip G, Patel J, MacFadyen R, Varma C
J Intern Med . 2009 Feb; 265(6):689-97. PMID: 19226374
Background: Nonesterified fatty acids (NEFA) and insulin have been implicated in the pathogenesis of diabetes mellitus (Type 2 diabetes) and coronary artery disease (CAD). We hypothesized that intracardiac levels of...
5.
The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure
Chung I, Goyal D, MacFadyen R, Lip G
Eur J Clin Invest . 2008 Feb; 38(3):150-8. PMID: 18257777
Background: Acute exercise has been associated with activation of thrombosis, and this risk may be accentuated in patients with heart failure. Given the relation of platelets to atherothrombosis, we tested...
6.
The ADVANCE trial: further PROGRESS with HOPE
Karthikeyan V, Bakris G, MacFadyen R
J Hum Hypertens . 2007 Oct; 21(12):911-3. PMID: 17960167
No abstract available.
7.
The 2007 revised ESC/ESH Guidelines in the management of hypertension: clarifying individual patient care
MacFadyen R
J Hum Hypertens . 2007 Jul; 21(10):757-61. PMID: 17637791
No abstract available.
8.
Extracellular matrix turnover and disease severity in Anderson-Fabry disease
Shah J, Hughes D, Tayebjee M, MacFadyen R, Mehta A, Elliott P
J Inherit Metab Dis . 2006 Dec; 30(1):88-95. PMID: 17160618
Background: Anderson-Fabry Disease (AFD) is an inherited metabolic disease associated with premature death secondary to cardiovascular and renal disease. Patients with AFD develop progressive left ventricular (LV) remodelling and heart...
9.
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty
Boos C, Jaumdally R, MacFadyen R, Varma C, Lip G
J Thromb Haemost . 2006 Dec; 5(3):630-2. PMID: 17155959
No abstract available.
10.
Does eplerenone have a future in the management of hypertension in Europe?
Gosse P, MacFadyen R
J Hum Hypertens . 2006 Aug; 20(11):829-32. PMID: 16915301
No abstract available.